Figure 3.

The percentage of drug combinations with respect to the proportion of different types of pathway pairs targeted by the combinations. (A) Cross-talking pathways. (B) Interacting pathways.

Wang et al. BMC Bioinformatics 2012 13(Suppl 7):S7   doi:10.1186/1471-2105-13-S7-S7